Cargando…
Co-targeting MCL-1 and ERK1/2 kinase induces mitochondrial apoptosis in rhabdomyosarcoma cells
The RAS/MEK/ERK genetic axis is commonly altered in rhabdomyosarcoma (RMS), indicating high activity of downstream effector ERK1/2 kinase. Previously, we have demonstrated that inhibition of the RAS/MEK/ERK signaling pathway in RMS is insufficient to induce cell death due to residual pro-survival MC...
Autores principales: | Winkler, Marius, Friedrich, Juliane, Boedicker, Cathinka, Dolgikh, Nadezda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681038/ https://www.ncbi.nlm.nih.gov/pubmed/34906889 http://dx.doi.org/10.1016/j.tranon.2021.101313 |
Ejemplares similares
-
Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells
por: Erdogdu, Ufuk, et al.
Publicado: (2021) -
The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells
por: Fischer, Kyra, et al.
Publicado: (2017) -
MCL-1ES Induces MCL-1L-Dependent BAX- and BAK-Independent Mitochondrial Apoptosis
por: Kim, Jae-Hong, et al.
Publicado: (2013) -
MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment
por: Alcon, Clara, et al.
Publicado: (2022) -
Mitochondrial IRG1 traps MCL-1 to induce hepatocyte apoptosis and promote carcinogenesis
por: Zhang, Liyuan, et al.
Publicado: (2023)